Scrip
Novartis's Afinitor gets EU approval for kidney cancer
06 August 2009
Malini Guha
Please Login to read the full article.
06 August 2009
Malini Guha
Malini.guha@informa.com
Novartis's mTOR inhibitor Afinitor (everolimus) has received EU approval for the treatment of advanced renal cell carcinoma patients whose disease progressed on or after treatment with the VEGF pathway inhibitors approved for the disease.
The
European Commission's approval for Afinitor to...
Please Login to read the full article.
RELATED CONTENT
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
